Redwood Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,711
Closed -$493K 315
2023
Q4
$493K Sell
1,711
-800
-32% -$218K 0.05% 286
2023
Q3
$675K Sell
2,511
-5,621
-69% -$1.4M 0.06% 263
2023
Q2
$1.8M Buy
+8,132
New +$1.89M 0.19% 127
2022
Q4
Sell
-6,614
Closed -$1.49M 250
2022
Q3
$1.49M Buy
+6,614
New +$1.6M 0.31% 53
2022
Q1
Sell
-8,502
Closed -$1.91M 275
2021
Q4
$1.91M Sell
8,502
-9,305
-52% -$1.96M 0.25% 88
2021
Q3
$3.79M Sell
17,807
-1,057
-6% -$243K 0.54% 45
2021
Q2
$4.6M Buy
18,864
+3,126
+20% +$769K 0.75% 27
2021
Q1
$3.89M Buy
15,738
+12,385
+369% +$2.96M 0.74% 20
2020
Q4
$771K Buy
+3,353
New +$773K 0.13% 198
2020
Q3
Sell
-3,822
Closed -$901K 241
2020
Q2
$901K Buy
3,822
+287
+8% +$65.5K 0.26% 75
2020
Q1
$717K Sell
3,535
-1,026
-22% -$224K 0.45% 68
2019
Q4
$1.1M Sell
4,561
-18,491
-80% -$4.08M 0.27% 103
2019
Q3
$4.46M Buy
23,052
+2,182
+10% +$419K 1.21% 18
2019
Q2
$3.86M Buy
20,870
+6,470
+45% +$1.16M 1.08% 21
2019
Q1
$2.74M Buy
+14,400
New +$2.75M 1.17% 35
2018
Q3
Sell
-1,280
Closed -$236K 131
2018
Q2
$236K Buy
+1,280
New +$226K 0.09% 100

Other funds holding AMGN

Redwood Investment Management's AMGN Position: Q1 2024 in Review

Redwood Investment Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 1,711 shares — an estimated $493K sold.

Redwood Investment Management first reported a position in AMGN in Q2 2018 and held it in 16 quarters. The position peaked at $4.6M in Q2 2021. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Redwood Investment Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Redwood Investment Management sold 1,711 Amgen shares in Q1 2024, an estimated $493K.
  • Redwood Investment Management first reported a position in Amgen in Q2 2018 and held it in 16 quarters.
  • Redwood Investment Management's Amgen position peaked at $4.6M in Q2 2021.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Redwood Investment Management's 13F filing for Q1 2024, filed 16 May 2024.